High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment

Docetaxel-induced fluid retention (DIFR) cumulatively occurs and is one of the most troublesome adverse effects. This study aimed to determine whether high dose dexamethasone (DEX) could prevent DIFR during breast cancer treatment. Breast cancer patients receiving docetaxel (75 mg/m(2))-containing r...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Yoshitaka, Kanno, Ryota, Takekuma, Yoh, Takeshita, Takashi, Oshino, Tomohiro, Sugawara, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247720/
https://www.ncbi.nlm.nih.gov/pubmed/37286589
http://dx.doi.org/10.1038/s41598-023-36264-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247720/
https://www.ncbi.nlm.nih.gov/pubmed/37286589
http://dx.doi.org/10.1038/s41598-023-36264-4

Ejemplares similares